News

Novo Nordisk downgraded to Neutral from Buy at Guggenheim
Guggenheim downgraded Novo Nordisk (NVO) to Neutral from Buy.Stay Ahead of the Market: Discover outperforming stocks and invest smarter with ...
Analysts Conflicted on These Healthcare Names: Novo Nordisk (NVO) and Sanofi (OtherSNYNF)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Novo Nordisk (NVO – Research Report) and ...